Cap Accreditation Achieved By Dubai Health Genomic Medicine Centre

Dubai Health has confirmed that its Genomic Medicine Centre has secured accreditation from the College of American Pathologists, recognising compliance with strict laboratory quality standards. The CAP status highlights Dubai Health’s focus on accuracy, safety, and reliability in genetic testing services offered to patients, clinicians, and researchers across the UAE and wider region.

The accreditation follows a structured assessment by a specialist CAP inspection team. The review checks whether laboratory processes, staff qualifications, equipment, and reporting methods align with internationally accepted benchmarks. CAP’s programme is regarded as one of the leading global schemes for medical laboratory quality assurance, designed to maintain high performance in routine and complex testing.

"The Genomic Medicine Centre also supports Dubai Health’s integrated academic health system model, as it is consisted of a team of physicians and researchers alongside students from Mohammed Bin Rashid University of Medicine and Health Sciences, the arm of learning and discovery of Dubai Health. This collaboration aims to transform biomedical discoveries into practical solutions that contribute to advancing healthcare services.

Dr. Ahmad Abou Tayoun, Director of the Genomic Medicine Centre at Dubai Health, stated deep satisfaction with the CAP recognition, which he described as proof of commitment to international quality benchmarks. Dr. Abou Tayoun said the accreditation reinforces the centre’s status as a leading regional hub for genomic medicine and supports advanced research activities linked to clinical care.

According to Dr. Abou Tayoun, the Genomic Medicine Centre plays a broad role within Dubai Health’s system. Teams analyse genomic data, provide consultations, and arrange long-term follow-up for individuals and families. These services help medical professionals choose precise, evidence-based treatment options using genetic information tailored to each patient’s condition and background.

The centre runs molecular genetics, genomics, and cytogenetics laboratories that cover a wide portfolio of tests. Services include genetic diagnosis of hereditary conditions, investigation of rare diseases, and a premarital genetic screening programme. Through these activities, the Genomic Medicine Centre contributes to public health initiatives in the UAE and supports planning for future healthcare needs.

With inputs from WAM